Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Continuous Treatment Study of JNS019 (Topiramate) in Migraine Patients

NCT01799590 is registered in ClinicalTrials.gov with Janssen Pharmaceutical K.K. as lead sponsor.

NCT NCT01799590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01799590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Continuous Treatment Study of JNS019 (Topiramate) in Migraine Patients
Lead sponsor
Janssen Pharmaceutical K.K.
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2007
Completion date
November 30, 2009
Enrollment
296 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

migraine